On January 22, 2016, United States District Judge F. Dennis Saylor IV denied pharmaceutical giant GlaxoSmithKline’s motion to dismiss lawsuits filed against the company regarding its anti-nausea medication Zofran. Many women who took Zofran for morning sickness during pregnancy gave birth to babies born with severe abnormalities, including cleft palates, congenital heart defects, club feet, vision and hearing issues, and

There are few circumstances more tragic than a child born with severe birth defects. Many women who took GlaxoSmithKline’s drug Zofran for morning sickness during their pregnancies gave birth to babies born with congenital heart defects, cleft palates and other abnormalities. Zofran was approved by the FDA to prevent nausea and vomiting in cancer patients undergoing chemotherapy. Soon after, it